Effects of sacubitric valsartan sodium tablets on contrast agent nephropathy in patients with chronic heart failure undergoing elective coronary percutaneous coronary intervention

CAO Jinlong, MA Honglan, XIN Hong, CAI Tianzhi, LIU Baixue, ZHANG Anji, MA Xiaochuan, ZHANG Kelin

PDF(1630 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1630 KB)
World Clinical Drug ›› 2021, Vol. 42 ›› Issue (06) : 478-482. DOI: 10.13683/j.wph.2021.06.010
Article

Effects of sacubitric valsartan sodium tablets on contrast agent nephropathy in patients with chronic heart failure undergoing elective coronary percutaneous coronary intervention

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 42(06): 478-482 https://doi.org/10.13683/j.wph.2021.06.010

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1630 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉